Financial insights of GEHC

MyFinsight

For the year ending 2025-12-31, GEHC made $20,625M in revenue. $2,084M in net income. Net profit margin of 10.10%.

Unit: Million (M) dollars (except for numbers of shares and EPS)

Income Statement	2025-12-31	2024-12-31	2023-12-31
Total revenues	20,625	19,672	19,552
Cost of sales-Product	8,942	8,271	8,465
Cost of sales-Service	3,436	3,196	3,165
Gross profit	8,248	8,205	7,922
Selling, general, and administrative	4,225	4,269	4,282
Research and development	1,260	1,311	1,205
Total operating expenses	5,485	5,580	5,487
Operating income	2,763	2,625	2,435
Interest and other financial charges net	440	504	542
Non-operating benefit (income) costs	-288	-406	-382
Net financing income and investment income (loss)	41	-1	26
Equity method income (loss)	3	8	11
Change in fair value of assumed obligations	-30	-32	-32
Gain on remeasurement of nmp equity method investment	97	-	-
Other items, net	46	80	81
Other (income) expense net	157	55	86
Income from continuing operations before income taxes	2,768	2,581	2,361
Benefit (provision) for income taxes	614	531	743
Net income from continuing operations	2,154	2,050	1,618
Income (loss) from discontinued operations, net of taxes	0	0	-4
Net income	2,154	2,050	1,614
Net (income) loss attributable to noncontrolling interests	70	57	46
Net income attributable to ge healthcare	2,084	1,993	1,568
Deemed preferred stock dividend of redeemable noncontrolling interest	0	0	183
Net income attributable to ge healthcare common stockholders	2,084	1,993	1,385

Basic (in dollars per share)	4.56	4.37	3.05
Basic (in shares)	456,000,000	456,000,000	455,000,000
Diluted (in dollars per share)	4.55	4.34	3.03
Diluted (in shares)	458,000,000	459,000,000	458,000,000